Publication | Closed Access

Anti-toll-like receptor 2 antibody ameliorates hepatic injury, inflammation, fibrosis and steatosis in obesity-related metabolic disorder rats via regulating MAPK and NF-κB pathways

Anti-toll-like Receptor 2ImmunologyImmune RegulationPathologyFatty Liver DiseaseNf-κb PathwaysObesityMetabolic SyndromeInflammationMetabolic SignalingCell SignalingHealth SciencesMetabolic Associated SteatohepatitisLiver PhysiologyChronic InflammationHepatology InflammationInflammatory DiseaseMetabolic HealthLiver DiseaseMedicineHepatic Injury